Stories

Newly signed law contains Collins’ bipartisan HOPE for Alzheimer’s Act

The roughly $1.4 trillion year-end omnibus package recently signed into law by the president includes bipartisan, bicameral legislation introduced by U.S. Sen. Susan Collins (R-ME) that requires the Centers for Medicare and Medicaid Services (CMS) to conduct outreach to healthcare practitioners around the services it provides for individuals with Alzheimer’s disease and related dementias.

“It is imperative that those living with Alzheimer’s disease and their families receive the resources they need, including information about treatment options and what medical and community services are available,” Sen. Collins said. “As the co-chair of the Senate Alzheimer’s Task Force, I will continue to support those living with Alzheimer’s disease and their caregivers.”

Sen. Collins in March 2019 cosponsored the Improving Health, Outcomes, Planning, and Education (HOPE) for Alzheimer’s Act, S. 880, with U.S. Sen. Shelley Moore Capito (R-WV) and bill sponsor U.S. Sen. Debbie Stabenow (D-MI). The identical bill, H.R. 1873, was simultaneously introduced by U.S. Reps. Jackie Walorski (R-IN) and Paul Tonka (D-NY) in the U.S. House of Representatives. 

Following efforts in 2015 by the lawmakers, CMS announced in November 2016 that Medicare would begin covering new care plans in 2017. 

“Fortunately, following our advocacy, CMS implemented a new rule in 2018 that allows Medicare beneficiaries to receive a care planning session,” said Sen. Collins. “Our legislation will expand access to this service by increasing awareness of this policy change among physicians.” 

The Improving HOPE for Alzheimer’s Act requires the U.S. Department of Health and Human Services to conduct outreach to ensure more healthcare providers are aware of this benefit and to report back on rates of utilization and barriers to access, according to a bill summary provided by Sen. Collins’ office.

The measure became law as part of the Consolidated Appropriations Act of 2021, H.R. 133, which President Donald Trump signed into law on Dec. 27.  

Alzheimer’s disease is the sixth-leading cause of death in the United States and more than 16 million Americans provide unpaid care for people suffering from Alzheimer’s disease, according to Sen. Collins’ office.

Ripon Advance News Service

Recent Posts

Smucker’s bipartisan bill closes Medicare loophole to ease transition from private healthcare

To help protect America’s senior citizens from coverage gaps in Medicare, U.S. Rep. Lloyd Smucker…

1 day ago

Wagner’s bipartisan bill forces reconsideration of U.S.-Qatar ally status

Strict guidelines would require the administration to review and consider terminating the designation of the…

1 day ago

Carter offers bipartisan, bicameral bill to create Georgia’s first National Park

U.S. Rep. Buddy Carter (R-GA) joined his home-state congressional delegates on April 30 to unveil…

1 day ago

House advances bipartisan Stauber bill to end restrictions on oil, gas development in Alaska

The U.S. House of Representatives on Wednesday approved bipartisan legislation led by U.S. Rep. Pete…

1 day ago

EV mandates would be reversed under two bipartisan Hoeven resolutions

U.S. Sen. John Hoeven (R-ND) on May 1 proposed two bipartisan resolutions of disapproval that…

1 day ago

Rounds cosponsors bipartisan AI Grand Challenges Act

Bipartisan legislation offered by U.S. Sen. Mike Rounds (R-SD) would create a new federal prize…

1 day ago

This website uses cookies.